1-11 of 11
Rikio Suzuki
Close
Sort by
Journal Articles

CD56 Is an Unfavorable Prognostic Factor for Acute Promyelocytic Leukemia: Results By Multivariate Analyses in the JALSG-APL204 Study

Akihiro Takeshita, MDPhD, Norio Asou, MD PhD, Yoshiko Atsuta, MD PhD, Hiroaki Furumaki, MD, Toru Sakura, PhD MD, Yasunori Ueda, MD PhD, Masashi Sawa, MD PhD, Nobuaki Dobashi, MD, Rikio Suzuki, MD PhD, Yasuhiro Taniguchi, MD, Masaru Nakagawa, MD PhD, Shigehisa Tamaki, MD, Maki Hagihara, MD PhD, Katsumichi Fujimaki, MD, Yasuhisa Yokoyama, MD PhD, Hiroyuki Fujita, MD PhD, Masamitsu Yanada, MD PhD, Yoshinobu Maeda, MD PhD, Noriko Usui, MD PhD, Yukio Kobayashi, MD DSc, Hitoshi Kiyoi, MD PhD, Shigeki Ohtake, MD PhD, Itaru Matsumura, MD, Tomoki Naoe, MD PhD, Yasushi Miyazaki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2798.
https://doi.org/10.1182/blood-2018-99-111638
Published: 2018
Journal Articles

The KDM3A-KLF2-IRF4 Axis Maintains Myeloma Cell Survival

Hiroto Ohguchi, MD PhD, Teru Hideshima, MDPhD, Manoj Bhasin, PhD, Gullu Gorgun, PhD, Loredana Santo, MD, Michele Cea, MD, Naoya Mimura, MD PhD, Rikio Suzuki, MDPhD, Yu-Tzu Tai, PhD, Ruben D. Carrasco, MD PhD, Noopur S. Raje, MD, Paul G. Richardson, MD, Hideo Harigae, MD PhD, Takaomi Sanda, MD PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2015) 126 (23): 3633.
https://doi.org/10.1182/blood.V126.23.3633.3633
Published: 2015
Journal Articles

Targeting Immune Suppressive Microenvironment By Immune Checkpoint Blockade in Multiple Myeloma

Gullu Topal Gorgun, PhD, Kristen Cowens, Steven Paula, Mehmet Kemal Samur, PhD, Hiroto Ohguchi, MD PhD, Ahaana Singh, Randie E White, Giada Bianchi, MD, Rikio Suzuki, MDPhD, Shohei Kikuchi, MDPhD, Takeshi Harada, MDPhD, Naoya Mimura, MD PhD, Yu-Tzu Tai, PhD, Teru Hideshima, MDPhD, Jacob P. Laubach, MD, Noopur Raje, MD, Nikhil C. Munshi, MD, Paul G. Richardson, Kenneth C. Anderson
Journal: Blood
Blood (2014) 124 (21): 27.
https://doi.org/10.1182/blood.V124.21.27.27
Published: 2014
Journal Articles

Synthetic Lethal Approaches to Exploit Replicative Stress in Aggressive Myeloma

Francesca Cottini, Teru Hideshima, MDPhD, Rikio Suzuki, MDPhD, Paul G. Richardson, Kenneth C. Anderson, MD, Giovanni Tonon, MDPhD
Journal: Blood
Blood (2014) 124 (21): 173.
https://doi.org/10.1182/blood.V124.21.173.173
Published: 2014
Journal Articles

Mimicking Myeloma Niche Ex Vivo

Jana Jakubikova, PhD, Danka Cholujova, PhD, Richard W Groen, PhD, Jungnam Joo, PhD, Sun-Young Kong, MD PhD, Teru Hideshima, MD PhD, Rikio Suzuki, MDPhD, Jan Sedlak, PhD, Constantine S Mitsiades, MD PhD, David M Dorfman, MD PhD, Jacob P. Laubach, MD, Nikhil C. Munshi, MD, Paul G. Richardson, MD PhD, Kenneth Anderson, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2076.
https://doi.org/10.1182/blood.V124.21.2076.2076
Published: 2014
Journal Articles

Antitumor Activities Of An Oral Selective HSP90α/β Inhibitor, TAS-116, In Combination With Bortezomib In Multiple Myeloma

Rikio Suzuki, MD, PhD, Teru Hideshima, MD, PhD, Shuichi Ohkubo, PhD, Naoya Mimura, MD, PhD, Jiro Minami, MD, PhD, Hiroto Ohguchi, MD, PhD, Shohei Kikuchi, MD, PhD, Diana D. Cirstea, Francesca Cottini, MD, Dharminder Chauhan, PhD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Teruhiro Utsugi, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2013) 122 (21): 4429.
https://doi.org/10.1182/blood.V122.21.4429.4429
Published: 2013
Journal Articles

Rational Combination Treatment of a Novel Selective mTOR Kinase Inhibitor AZD8055 with IGF-1R Inhibitors in Multiple Myeloma

Diana Cirstea, Teru Hideshima, MD, PhD, Loredana Santo, Homare Eda, Tyler A. Scullen, Neeharika Nemani, Anuj Mahindra, Andrew Yee, Yiguo Hu, Naoya Mimura, Jiro Minami, Hiroto Ohguchi, Rikio Suzuki, Francesca Cottini, Sylvie M Guichard, Kenneth C. Anderson, Noopur Raje
Journal: Blood
Blood (2012) 120 (21): 4023.
https://doi.org/10.1182/blood.V120.21.4023.4023
Published: 2012
Journal Articles

TAS-117, a Novel Selective Akt Inhibitor Demonstrates Significant Growth Inhibition in Multiple Myeloma Cells in Vitro and in Vivo

Naoya Mimura, Hiroto Ohguchi, Diana Cirstea, MD, Francesca Cottini, Gullu Topal Gorgun, PhD, Jiro Minami, Rikio Suzuki, Toshiyasu Shimomura, PhD, Teruhiro Utsugi, PhD, Teru Hideshima, MD, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2012) 120 (21): 942.
https://doi.org/10.1182/blood.V120.21.942.942
Published: 2012
Journal Articles

Preferential Hypermethylation of the DKK-1 Promoter in Core-Binding Factor Leukaemia.

Rikio Suzuki, MD, Makoto Onizuka, M.D., Minoru Kojima, M.D., Masako Shimada, M.D., Satomi Fukagawa, M.D., Kosuke Tsuboi, M.D., Hiroyuki Kobayashi, Ph.D, Ayumi Shintani, Ph.D, Yoshiaki Ogawa, Ph.D, Hiroshi Kawada, Ph.D, Tomomitsu Hotta, Ph.D, Kiyoshi Ando, Ph.D
Journal: Blood
Blood (2007) 110 (11): 4136.
https://doi.org/10.1182/blood.V110.11.4136.4136
Published: 2007
Journal Articles

Association of Fc Receptor-Like Protein Family with Chronic Graft-Versus-Host Disease.

Makoto Onizuka, Masako Toyosaki, Shinichiro Machida, Rikio Suzuki, Minoru Kojima, Koichi Miyamura, Yoshihisa Kodera, Hidetoshi Inoko, Kiyoshi Ando
Journal: Blood
Blood (2007) 110 (11): 2970.
https://doi.org/10.1182/blood.V110.11.2970.2970
Published: 2007
Journal Articles

Clinical Significance of FLT3/ITD and NPM1 Mutation in Acute Myeloid Leukemia (AML).

Rikio Suzuki, Makoto Onizuka, Masako Shimada, Yasunobu Iwaki, Hiroshi Kawada, Yoshiaki Ogawa, Tomomitsu Hotta, Kiyoshi Ando
Journal: Blood
Blood (2006) 108 (11): 4442.
https://doi.org/10.1182/blood.V108.11.4442.4442
Published: 2006